Trials / Completed
CompletedNCT04704440
Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension With/Without Sildenafil
Hemodynamic Effects of Acute Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension: Single-center Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To study the effect of acute normobaric hypoxia during exercise in patients with pulmonary hypertension with/without Sildenafil
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Normobaric hypoxia (FiO2 15%) | Inhalation of deoxygenated air through an altitude simulator ("Altitrainer"), for approx. 1/2 hour given by a facemask, first at rest and then during exercise. |
| OTHER | Placebo-ambient air (FiO2 21%) | Inhalation of room air through an altitude simulator ("Altitrainer"), for approx. 1/2 hour given by a facemask, first at rest and then during exercise. |
| OTHER | Normobaric hypoxia (FiO2 15%) under Sildenafil | Inhalation of deoxygenated air through an altitude simulator ("Altitrainer"), for approx. 1/2 hour given by a facemask, first at rest and then during exercise. |
| OTHER | Placebo-ambient air (FiO2 21%) under Sildenafil | Inhalation of room air through an altitude simulator ("Altitrainer"), for approx. 1/2 hour given by a facemask, first at rest and then during exercise. |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2023-05-31
- Completion
- 2023-05-31
- First posted
- 2021-01-11
- Last updated
- 2023-06-06
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04704440. Inclusion in this directory is not an endorsement.